Spotlight on Emerging Immunotherapy Approaches and MET Inhibitors in Advanced NSCLC, brought to you by Ology Medical Education, was originally presented as a live, CME-certified 90-minute satellite symposium at the IASLC 2019 World Conference on Lung Cancer in Barcelona, Spain. A webcast with a transcript and downloadable slides from the live symposium will be hosted on this website for a period of 1 year, in order to extend the reach of the live programme.
Course opens: October 2019
Course expires: October 2020
This programme is intended for oncologists, pulmonologists, pathologists and respiratory physicians involved in the diagnosis, treatment, and management of patients with advanced NSCLC.
After watching the webcast, you will be able to:
What is the current clinical status of novel immunotherapies in advanced NSCLC?
What does the latest evidence reveal for emerging MET inhibitors?
Are we optimally prepared to provide personalized treatment strategies?
Ology Medical Education
This program was approved by the IASLC 2019 World Conference on Lung Cancer Program Committee as an independent activity held in conjunction with the IASLC 2019 World Conference on Lung Cancer. This program is not sponsored or endorsed by IASLC and is not part of the official IASLC accredited program.